AAAAAA
Results: 1-25/65
Authors:
Schmidinger, M
Stager, G
Wenzel, C
Locker, GJ
Budinsky, AC
Brodowicz, T
Kramer, G
Marberger, M
Zielinski, CC
Citation: M. Schmidinger et al., Sequential administration of interferon-gamma, GM-CSF, and interleukin-2 in patients with metastatic renal cell carcinoma: Results of a phase II trial, J IMMUNOTH, 24(3), 2001, pp. 257-262
Authors:
Kramer, G
Steiner, GE
Sokol, P
Handisurya, A
Klingler, HC
Maier, U
Foldy, M
Marberger, M
Citation: G. Kramer et al., Local intratumoral tumor necrosis factor-alpha and systemic IFN-alpha 2b in patients with locally advanced prostate cancer, J INTERF CY, 21(7), 2001, pp. 475-484
Authors:
Reiter, WJ
Brodowicz, T
Alavi, S
Zielinski, CC
Kozak, W
Maier, U
Nost, G
Lipsky, H
Marberger, M
Kratzik, C
Citation: Wj. Reiter et al., Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminoma, J CL ONCOL, 19(1), 2001, pp. 101-104
Authors:
Djavan, B
Waldert, M
Seitz, C
Marberger, M
Citation: B. Djavan et al., Insulin-like growth factors and prostate cancer, WORLD J URO, 19(4), 2001, pp. 225-233
Authors:
Klingler, HC
Marberger, M
Citation: Hc. Klingler et M. Marberger, Bulking agents in the treatment of female urinary stress incontinence. Therapeutic approach to female stress incontinence, UROLOGE A, 40(4), 2001, pp. 281
Authors:
Kramer, G
Steiner, GE
Paiha, S
Handisurya, A
Djavan, B
Mallone, R
Marberger, M
Citation: G. Kramer et al., Human accessory cells activate fresh, normal, tumor-distant T lymphocytes but not tumor-infiltrating T lymphocytes to lyse autologous tumor cells in a primary cytotoxic T lymphocyte assay in renal cell carcinoma, EUR UROL, 40(4), 2001, pp. 427-433
Authors:
Reiter, WJ
Schatzl, G
Mark, I
Zeiner, A
Pycha, A
Marberger, M
Citation: Wj. Reiter et al., Dehydroepiandrosterone in the treatment of erectile dysfunction in patients with different organic etiologies, UROL RES, 29(4), 2001, pp. 278-281
Authors:
Handisurya, A
Steiner, GE
Stix, U
Ecker, RC
Pfaffeneder-Mantai, S
Langer, D
Kramer, G
Memaran-Dadgar, N
Marberger, M
Citation: A. Handisurya et al., Differential expression of interleukin-15, a pro-inflammatory cytokine andT-cell growth factor, and its receptor in human prostate, PROSTATE, 49(4), 2001, pp. 251-262
Authors:
Djavan, B
Mazal, P
Zlotta, A
Wammack, R
Ravery, V
Remzi, M
Susani, M
Borkowski, A
Hruby, S
Boccon-Gibod, L
Schulman, CC
Marberger, M
Citation: B. Djavan et al., Pathological features of prostate cancer detected on initial and repeat prostate biopsy: Results of the prospective European Prostate Cancer Detection Study, PROSTATE, 47(2), 2001, pp. 111-117
Authors:
Schatzl, G
Madersbacher, S
Thurridl, T
Waldmuller, J
Kramer, G
Haitel, A
Marberger, M
Citation: G. Schatzl et al., High-grade prostate cancer is associated with low serum testosterone levels, PROSTATE, 47(1), 2001, pp. 52-58
Authors:
Lodde, M
Mian, C
Wiener, H
Haitel, A
Pycha, A
Marberger, M
Citation: M. Lodde et al., Detection of upper urinary tract transitional cell carcinoma with ImmunoCyt: A preliminary report, UROLOGY, 58(3), 2001, pp. 362-366
Authors:
Haitel, A
Wiener, HG
Neudert, B
Marberger, M
Susani, M
Citation: A. Haitel et al., Expression of the cell cycle proteins p2l, p27, and pRb in clear cell renal cell carcinoma and their prognostic significance, UROLOGY, 58(3), 2001, pp. 477-481
Authors:
Schatzl, G
Gsur, A
Bernhofer, G
Haidinger, G
Hinteregger, S
Vutuc, C
Haitel, A
Micksche, M
Marberger, M
Madersbacher, S
Citation: G. Schatzl et al., Association of vitamin D receptor and 17 hydroxylase gene polymorphisms with benign prostatic hyperplasia and benign prostatic enlargement, UROLOGY, 57(3), 2001, pp. 567-572
Authors:
Djavan, B
Seitz, C
Roehrborn, CG
Remzi, M
Fakhari, M
Waldert, M
Basharkhah, A
Planz, B
Harik, M
Marberger, M
Citation: B. Djavan et al., Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: Outcomes at 18 months, UROLOGY, 57(1), 2001, pp. 66-70
Authors:
Djavan, B
Ravery, V
Zlotta, A
Dobronski, P
Dobrovits, M
Fakhari, M
Seitz, C
Susani, M
Borkowski, A
Boccon-Gibod, L
Schulman, CC
Marberger, M
Citation: B. Djavan et al., Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and4: When should we stop?, J UROL, 166(5), 2001, pp. 1679-1683
Authors:
Djavan, B
Waldert, M
Zlotta, A
Dobronski, P
Seitz, C
Remzi, M
Borkowski, A
Schulman, C
Marberger, M
Citation: B. Djavan et al., Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: Results of a prospective European prostate cancer detection study, J UROL, 166(3), 2001, pp. 856-860
Authors:
Planz, B
Wang, QF
Kirley, SD
Marberger, M
McDougal, WS
Citation: B. Planz et al., Regulation of keratinocyte growth factor receptor and androgen receptor inepithelial cells of the human prostate, J UROL, 166(2), 2001, pp. 678-683
Authors:
Haitel, A
Posch, B
El-Baz, M
Mokhtar, AA
Susani, M
Ghoneim, MA
Marberger, M
Citation: A. Haitel et al., Bilharzial related, organ confined, muscle invasive bladder cancer: Prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2, J UROL, 165(5), 2001, pp. 1481-1487
Authors:
Gsur, A
Haidinger, G
Hinteregger, S
Bernhofer, G
Schatzl, G
Madersbacher, S
Marberger, M
Vutuc, C
Micksche, M
Citation: A. Gsur et al., Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk, INT J CANC, 95(3), 2001, pp. 152-155
Authors:
Haitel, A
Wiener, HG
Baethge, U
Marberger, M
Susani, M
Citation: A. Haitel et al., mdm2 expression as a prognostic indicator in clear cell renal cell cat-cinema: Comparison with p53 overexpression and clinicopathological parameters, CLIN CANC R, 6(5), 2000, pp. 1840-1844
Authors:
Schmidinger, M
Steger, GG
Budinsky, AC
Wenzel, C
Brodowicz, T
Locker, GJ
Kramer, G
Marberger, M
Zielinski, CC
Citation: M. Schmidinger et al., Vinorelbine and interferon-alpha 2c as second-line therapy in metastatic renal cell carcinoma, ANTI-CANC D, 11(3), 2000, pp. 175-179
Authors:
Djavan, B
Marberger, M
Citation: B. Djavan et M. Marberger, Transurethral microwave thermotherapy: An alternative to medical management in patients with benign prostatic hyperplasia?, J ENDOUROL, 14(8), 2000, pp. 661-669
Authors:
Schmidinger, M
Steger, GG
Wenzel, C
Locker, GJ
Brodowicz, T
Budinsky, AC
Wiltschke, C
Kramer, G
Marberger, M
Zielinski, CC
Citation: M. Schmidinger et al., Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial, CANCER IMMU, 49(7), 2000, pp. 395-400
Authors:
Djavan, B
Zlotta, AR
Ekane, S
Remzi, M
Kramer, G
Roumeguere, T
Etemad, M
Wolfram, R
Schulman, CC
Marberger, M
Citation: B. Djavan et al., Is one set of sextant biopsies enough to rule out prostate cancer? Influence of transition and total prostate volumes on prostate cancer yield, EUR UROL, 38(2), 2000, pp. 218-224
Authors:
Madersbacher, S
Schatzl, G
Djavan, B
Stulnig, T
Marberger, M
Citation: S. Madersbacher et al., Long-term outcome of transrectal high-intensity focused ultrasound therapyfor benign prostatic hyperplasia, EUR UROL, 37(6), 2000, pp. 687-694